Disparities in direct acting antivirals uptake in HIV‐hepatitis C co‐infected populations in Canada

BACKGROUND: Direct acting antivirals (DAAs) have revolutionized hepatitis C (HCV) treatment with >90% cure rates even in real‐world studies, giving hope that HCV can be eliminated. However, for DAAs to have a population‐level impact on the burden of HCV disease, treatment uptake needs to be expan...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeed, Sahar, Strumpf, Erin C, Moodie, Erica EM, Young, Jim, Nitulescu, Roy, Cox, Joseph, Wong, Alexander, Walmsely, Sharon, Cooper, Curtis, Vachon, Marie‐Lousie, Martel‐Laferriere, Valerie, Hull, Mark, Conway, Brian, Klein, Marina B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810331/
https://www.ncbi.nlm.nih.gov/pubmed/29116684
http://dx.doi.org/10.1002/jia2.25013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810331/
https://www.ncbi.nlm.nih.gov/pubmed/29116684
http://dx.doi.org/10.1002/jia2.25013

Ejemplares similares